This risk may be compounded when taking semaglutide, necessitating more vigilant monitoring and potential supplementation in elderly patients
In addition, many questions remain about the long-term effectiveness and risks of these drugs as well as whether there are differences between GLP-1 formulations
This is a positive development, even if it was born from a negative event
Portal-based communication is used for order status, intake questions, and administrative follow-up
Moreover, early clinical trials and real-world evidence have shown promising results regarding Semaglutides safety, tolerability, and efficacy in lupus patients, suggesting its potential as an adjunctive therapy in comprehensive lupus management
This phase focuses on preserving results and supporting ongoing health improvements